Our goal at JWM Neurology is to help diagnose, treat, maintain and improve the lives patients who have suspected or confirmed multiple sclerosis.
All of our neurologists diagnose and treat patients who have multiple sclerosis as well as all types of neurological conditions and sleep disorders.
At the JWM Neurology Center For Multiple Sclerosis:
Over the past several years, our practice has become very active in clinical research. Through the work of neurologist Craig E. Herrman, MD, and his research staff, we have a dedicated JWM Research Division that offers numerous clinical trials for neurological conditions. Regardless of the type of MS that patients have, there are various trials available. Patients who do not currently qualify for one of our trials will be given the option to be put on a list for future opportunities.
JWM Neurology has several studies which are ongoing at all times. These encompass patients with not only relapsing remitting multiple sclerosis but also those with a first clinical event – or even those with a more progressive course of the disease. Studies range from new disease-modifying agents to medications that will improve the everyday symptoms seen in MS. Kristina Cleveland, (our clinical research manager) along with her staff, is dedicated to patient care and continuing to expand our JWM Neurology research opportunities.
The treatment of multiple sclerosis has become increasingly challenging over the past several years. There are multiple treatment options currently available in the general market and in research studies as well as those currently awaiting FDA approval. Physicians treating MS will need to be able to balance the use of reliable "older" medicines with those coming to market.
It is an exciting time in the field of multiple sclerosis. Injections, oral medications, monthly infusions and even yearly infusions are potential options. However, with each mode of therapy there are clear drawbacks. Through the collective expertise of our physicians at JWM Neurology, we are able to educate patients and make informed, joint decisions on the best treatment to pursue. Each patient will likely be different, and the treatment will not only differ based on potential side effects, but also on lifestyle and the particular variety of multiple sclerosis.
Craig E. Herrman, M.D.
Craig E. Herrman, MD, is an Indiana native. He graduated with a Bachelor of Science from Purdue University with high distinction. It was at Purdue that he became intrigued with neuroscience. He attended Indiana University School of Medicine and graduated at the top of his class. He then completed his Neurology residency at University of Rochester in upstate New York. There, he was able to work under several experts in Multiple Sclerosis and neuroimmunology. Before moving back to Indiana he completed an extra year of training in a Fellowship, specializing in neuromuscular disease.
Dr. Herrman has practiced at JWM Neurology since 2005. He has been the Principle Investigator for over 25 clinical trials, most involving the treatment of Multiple Sclerosis. This has included trials on nearly all of the newly-approved medications over the past decade, and many which may be approved in the short-term future. This provides him an important level understanding and experience with these new medications.
Patients with a first diagnosis of multiple sclerosis or suspected multiple sclerosis have many questions. The National Multiple Sclerosis Society has a very informative website which answers many of those questions (see the “Q&A” section on their homepage).